SEC
SlamSEC
SearchBrowseEarnings

NKGen Biotech, Inc.

Biological Products, (No Diagnostic Substances)·SANTA ANA, CA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(270 total)

TypeDateAccessionPeriodSize
8-K
Feb 26, 2026
0001213900-26-020876CURRENT REPORT
Feb 20, 2026
253.4 KB
8-K
Feb 5, 2026
0001213900-26-012879CURRENT REPORT
Jan 30, 2026
254.5 KB
8-K
Jan 26, 2026
0001213900-26-007794CURRENT REPORT
Jan 20, 2026
279.1 KB
10-Q
Jan 20, 2026
0001845459-26-00000310-Q
Mar 31, 2025
10.0 MB
8-K
Jan 16, 2026
0001213900-26-005260CURRENT REPORT
Jan 12, 2026
253.2 KB
8-K
Jan 9, 2026
0001213900-26-003030CURRENT REPORT
Jan 5, 2026
362.2 KB
10-K
Oct 8, 2025
0001845459-25-00000410-K
Dec 31, 2024
16.7 MB
8-K
Sep 29, 2025
0001213900-25-093062CURRENT REPORT
Sep 25, 2025
274.6 KB
8-K
Sep 24, 2025
0001213900-25-091112CURRENT REPORT
Sep 18, 2025
639.4 KB
8-K
Sep 9, 2025
0001213900-25-085858CURRENT REPORT
Sep 4, 2025
267.4 KB
8-K
Jul 17, 2025
0001213900-25-065162CURRENT REPORT
Jul 14, 2025
758.5 KB
25-NSE
Jul 17, 2025
0001354457-25-000685
—
4.7 KB
8-K
Jul 16, 2025
0001213900-25-064774CURRENT REPORT
Jul 14, 2025
662.7 KB
8-K
Jun 20, 2025
0001213900-25-055833CURRENT REPORT
Jun 18, 2025
238.6 KB
SCHEDULE 13D
Jun 2, 2025
0001104659-25-055326
—
23.2 KB
4
Jun 2, 2025
0001104659-25-055325OWNERSHIP DOCUMENT
May 27, 2025
10.7 KB
8-K
May 20, 2025
0001213900-25-045648CURRENT REPORT
May 14, 2025
619.5 KB
NT 10-Q
May 15, 2025
0001213900-25-044178NOTIFICATION OF LATE FILING
Mar 31, 2025
20.1 KB
SCHEDULE 13G/A
May 15, 2025
0001172661-25-002127
—
9.7 KB
SCHEDULE 13D
May 12, 2025
0001213900-25-042042
—
8.3 KB
8-K
May 8, 2025
0001213900-25-040810CURRENT REPORT
May 5, 2025
640.2 KB
4
May 7, 2025
0001213900-25-040627OWNERSHIP DOCUMENT
May 5, 2025
7.2 KB
8-K
May 1, 2025
0001213900-25-038427CURRENT REPORT
Apr 25, 2025
270.8 KB
8-K
Apr 22, 2025
0001213900-25-034184CURRENT REPORT
Apr 21, 2025
271.8 KB
NT 10-K
Mar 31, 2025
0001213900-25-026395NOTIFICATION OF LATE FILING
Dec 31, 2024
17.8 KB
25 filings shown
CEO
Song Paul Y.
CFO
Graf James A